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Abstract Hexokinase I is comprised of homologous N- and C-
terminal domains, and binds to the outer membrane of
mitochondria. Reported here is the structure of a new crystal
form of recombinant human hexokinase I, which complements
existing crystal structures. Evidently, in some packing environ-
ments and even in the presence of glucose and glucose 6-
phosphate the N-terminal domain (but not the C-terminal
domain) can undergo oscillations between closed and partially
opened conformations. Subunit interfaces, present in all known
crystal forms of hexokinase I, promote the formation of linear
chains of hexokinase I dimers. Presented is a model for
membrane-associated hexokinase I, in which linear chains of
hexokinase I dimers are stabilized by interactions with
mitochondrial porin.
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1. Introduction
Hexokinase (ATP: D-hexose 6-phosphotransferase, EC
2.7.1.1) catalyses the phosphorylation of glucose, using ATP
as a phosphoryl donor. Four isoforms of hexokinase exist in
mammalian tissue [1]. Isozymes I, II, and III have molecular
weights of approximately 100 000 and exhibit 70% sequence
identity [2]. The N- and C-terminal halves of isozymes I^III
are similar in sequence and protein fold, a consequence per-
haps of the duplication and fusion of an ancestral gene [2^5].
Mammalian hexokinase IV (glucokinase) and yeast hexoki-
nase isoforms A and B have molecular weights of 50 000
and are similar in sequence to both halves of hexokinase I [2].
Hexokinase I is a ‘pacemaker’ of glycolysis in insulin inde-
pendent tissues such as brain, erythrocytes and heart [6,7].
The C-half of the type I isozyme is active [8,9], whereas the
N-half exhibits no activity [8,10]. Glucose 6-phosphate (Gluc-
6-P), the product of the hexokinase reaction, is a potent in-
hibitor of the type I isozyme. Phosphate (Pi), probably in
concert with glucose [11], reverses the inhibition of Gluc-6-P
by binding to a site located entirely within the N-terminal half
of the enzyme [11,12]. Hexokinase I in vivo is associated with
pores of the outer membrane of mitochondria, speci¢cally at
tight junctions where the inner and outer membranes of the
mitochondrion are in contact [13]. In its membrane associated
state, hexokinase I is putatively an oligomer [14^17]. Mem-
brane-associated hexokinase may be one component of a mul-
tiprotein complex, which channels ATP to hexokinase I and
ADP back to the matrix of the mitochondrion [13,18,19].
Crystal structures of recombinant human hexokinase I
complexed with either glucose/Gluc-6-P or glucose/Pi [11,20]
demonstrate two conformational states for the C-terminal do-
main, similar to the open and closed forms of yeast hexoki-
nase [21,22]. In the same crystal structures, however, the N-
terminal domains are always closed. In the glucose/Pi com-
plex, glucose and Pi bind to closed N-terminal domains of a
hexokinase I dimer, whereas in the glucose/Gluc-6-P complex
N-terminal domains of the dimer are closed with single glu-
cose and Gluc-6-P molecules. Clearly Pi must bind to the N-
terminal domain and cause a conformational change which
relieves product inhibition. The most reasonable conforma-
tional change is a transition from an open to closed confor-
mation [11].
Multiple crystal forms of a protein under the same state of
ligation can often provide insight regarding the conformation-
al dynamics of the protein, as well as reveal clear preferences
for protein subunit interactions. Presented here is a second
crystal form of the glucose/Gluc-6-P complex of hexokinase.
Although the conformation of the dimer in the new crystal
form is essentially identical to its predecessor, signi¢cant dif-
ferences in lattice contacts have a profound in£uence on the
dynamics (as measured by thermal parameters) of the N-ter-
minal domains. In addition, one set of packing contacts be-
tween dimers are identical in the two crystal forms, and are
related to a lattice contact observed in the glucose/Pi complex.
That interface could facilitate e⁄cient packing of hexokinase I
dimers on a membrane surface.
2. Materials and methods
Recombinant human hexokinase I was prepared as described pre-
viously [11,20]. Crystals of hexokinase I were grown by the hanging
drop method. The enzyme, stored in 25 mM potassium phosphate, pH
7.0, and 2 mM glucose, was transferred to a solution of 20 mM Gluc-
6-P, pH 7.5, by repetitive cycles of concentration-¢ltration and redi-
lution. 3.5 Wl of the resulting solution (20 mg/ml protein concentra-
tion) was combined with an equal volume of precipitant solution
containing 6^7% (w/v) polyethylene glycol 8000 (Sigma), 20 mM
Gluc-6-P, 1 mM glucose, 0.1^0.2 M sodium acetate, and 0.1 M so-
dium citrate, pH 5.6^6.0. The drops were equilibrated against 0.7 ml
of precipitant solution. Crystals grew as prismatic needles to
0.5U0.2U0.2 mm.
Prior to data collection crystals were transferred to a solution of
12% (w/v) polyethylene glycol 8000, 10 mM Gluc-6-P, 5 mM glucose
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and 0.1 M sodium citrate, pH 6.0. X-ray data were collected on SSRL
beam line 7-1, using a wavelength of 1.08 Aî and an 18-cm image plate
detector (MAR Research, Hamburg) with a crystal-to-detector dis-
tance of 22 cm. Each of 130 frames were collected over an oscillation
range of 0.9‡ and 15 s at a temperature of 4‡C. Approximately 10
frames were collected before the onset of signi¢cant radiation damage,
whereupon an unexposed portion of the crystal was translated into
the X-ray beam. Two crystals were required for a complete data set.
Data were processed with DENZO/SCALEPACK [23] and programs
from the CCP4 suite [24].
X-ray data were consistent with the space group P21. The asym-
metric unit is an entire dimer, and the solvent content of the crystal is
66% of its total volume. As evidenced by a self-rotation function, the
non-crystallographic two-fold axis of the dimer is 56‡ from the two-
fold screw axis. Molecular replacement using the previous glucose/
Gluc-6-P complex [20] resulted in an unambiguous solution. Rigid
body re¢nement of the initial molecular replacement solution gave a
correlation coe⁄cient of 0.67 and an R-factor of 0.39 for data to 4 Aî
resolution. Further re¢nement used XPLOR 3.851 [25] and parame-
ters from Engh and Huber [26], as described elsewhere [20]. Model
building employed a Silicon Graphics workstation (Indigo2 XL) and
the software TOM [27]. Non-crystallographic restraints were applied
to all protein atoms of the dimer (excluding 41 residues in lattice
contacts), and resulted in better R-factors during re¢nement. Re-
straints were applied to thermal parameters as before [20]. Ligands
were modeled against omit electron density maps based on phases
from the ¢rst cycle of re¢nement.
Surface areas involved in lattice and subunit contacts were calcu-
lated using programs in the CCP4 suite [24].
3. Results and discussion
The new crystal form of recombinant human hexokinase I,
complexed with glucose and Gluc-6-P, belongs to the space
group P21 (a = 83.8, b = 178.0, c = 88.4, L= 91.2‡) and di¡racts
to a resolution of 2.4 Aî . Resource limitations (synchrotron
time) limited data collection to 2.8 Aî . The model reported
from re¢nement has good stereochemistry and R-factors (Ta-
ble 1). Coordinates and structure factors have been deposited
with the Protein Data Bank at Brookhaven. The uncertainty
in the positions of atoms is approximately 0.3 Aî . On the basis
of PROCHECK [28], all residues fall within the generously
allowed regions of the Ramachandran plot and other catego-
ries of geometry are as good or better than those of a typical
structure of 2.8 Aî resolution. Thermal parameters for the
model vary from 5 to 100 Aî 2.
The previously reported glucose/Gluc-6-P complex [20]
(P21, a = 83.4, b = 121.8, c = 122.5, L= 92.6‡) and the crystal
form reported here exhibit di¡erent packing modes of essen-
tially the same hexokinase I dimer. Glucose and Gluc-6-P
bind to each N- and C-domain, and all domains are in a
closed conformation. The root-mean-square deviation over
all corresponding CK atoms in the two glucose/Gluc-6-P com-
plexes is 0.93 Aî , signi¢cantly higher than the deviation of
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Fig. 1. Variation of thermal parameters based on a hinged oscillator model. A: Stereoview of the magnitude of observed displacement of CK
positions due to the hinged conformational change of the C-terminal domain of hexokinase I. Line thicknesses are scaled according to the mag-
nitude of CK displacements. Thickest lines represent displacements as large as 7.0 Aî and thin lines represent displacements of 0.7 Aî . Filled
circles represent the centers of three hinges which allow the rigid body movements in the small and large subdomains (see [11] for details).
B: Stereoview of the variation in thermal parameters of the N-terminal domain of chain A of the previous glucose/Gluc-6-P complex. Line
thicknesses are scaled according to B-values. Thickest lines represent B-values above 70 Aî 2 and thin lines represent B-values below 20 Aî 2. Ball-
and-stick models represent bound glucose and Gluc-6-P molecules.
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individually superimposed domains (approximately 0.3 Aî ).
The di¡erence above re£ects rigid body displacements of
0.2^0.5 Aî for individual domains, presumably a consequence
of di¡erent packing environments.
The N-terminal domains in the previous glucose/Gluc-6-P
complex have uniformly high thermal parameters relative to
the C-terminal domains [20]. (The average thermal parameters
for the N-terminal domains of chains A and B are 58 and 46
Aî 2, respectively, as compared to the 35 and 39 Aî 2 of the C-
terminal domains.) In the new complex, domain-averaged
thermal parameters are lower and more uniform (Table 1).
The B-values for ligands in all domains are comparable to
B-values of nearby side chain atoms in both the previous
and new structures. Furthermore, the domains all adopt the
same closed conformation, as noted above. Hence, the di¡er-
ences in domain-averaged thermal parameters of the two crys-
tal forms must originate from di¡erences in the crystalline
packing environment. The disorder exhibited by the N-termi-
nal domains of the previous crystal form can arise from static
packing displacements and/or the conformational dynamics of
individual domains.
The elevated thermal parameters of the N-terminal domains
of the previous crystal form, relative to the new form, may be
due to the hinged oscillation of the N-terminal domains be-
tween a closed and partially opened conformation. Indeed, the
transition between open and closed conformers of the C-ter-
minal half is due to the hinged movement of its small and
large subdomains, and a similar conformational change has
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Fig. 2. Stereoview of contacts between dimers generated by the a interface. A: Contact observed in new glucose/Gluc-6-P complex. The identi-
cal contact exists in the previous glucose/Gluc-6-P complex [20]. B: Contact observed in the glucose/Pi complex [11]. Line thicknesses scaled ac-
cording to thermal parameters as in Fig. 1.
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been proposed for the N-terminal domain [11]. Hinged oscil-
lations between closed and open domain conformations pro-
duce a characteristic distribution in the displacement of CK
atoms, which compares favorably with the observed distribu-
tion in thermal parameters of the previous crystal form (Fig.
1). Some elements of secondary structure, however, clearly
behave independently of a hinged oscillation model. For in-
stance, the extended loop 95^105 has thermal parameters well
in excess of those projected by a hinged oscillation, and seg-
ment 445^450 (corresponding to a known hinge element of the
C-terminal domain [11]) also departs from a hinged oscillation
model. Furthermore, the analysis above cannot distinguish
between static packing disorder (the presence of closely re-
lated, but ¢xed conformations) and dynamic disorder (free
oscillation between conformational states). Nonetheless, the
kind of disorder exhibited by the N-terminal domains suggests
that Gluc-6-P and glucose together are only marginally e¡ec-
tive in stabilizing a closed conformation in the previous crys-
tal form. On the other hand, irrespective of packing environ-
ment, glucose and Gluc-6-P stabilize closed C-terminal
domains, with little evidence of static and/or dynamic disor-
der. The above is consistent with a recent study in directed
mutation and kinetics which supports a low a⁄nity site for
Gluc-6-P at the N-terminal domain and a high a⁄nity site at
the C-terminal domain [12]. In conjunction with the glucose/Pi
complex, which presents an open C-terminal domain in the
context of a similar hexokinase I dimer [11], the above sug-
gests the absence of signi¢cant energy barriers to conforma-
tional transitions of individual domains in the structural con-
text of the dimer.
Protein-protein interactions within the two glucose/Gluc-6-
P crystal forms and the glucose/Pi crystal form reveal similar
(and extensive) interfaces between polypeptide chains. These
extensive interfaces, which de¢ne dimers of hexokinase I, each
represent a larger area of contact (by 3- to 6-fold) than other
subunit interfaces. Only a contact between the C-terminal
halves (Fig. 2) is strictly conserved in the two glucose/Gluc-
6-P complexes. This contact (hereafter called interface a) may
represent a signi¢cant contribution to the free energy of crys-
tallization. Crystals of both glucose/Gluc-6-P complexes grow
as prismatic needles. The axis de¢ned by the needle represents
the direction of most rapid growth, and re£ects the rapid
concatenation of hexokinase I dimers (by way of this a inter-
face) into linear chains. A modi¢ed form of the a interface
appears in the glucose/Pi complex (Fig. 2), which also pro-
motes the growth of prismatic needles. Furthermore, all ex-
amples of the a interface (which include the C-terminal do-
main both open and closed) involve residues with low B-
values (Fig. 2), representing some of the most conformation-
ally stabile structures of hexokinase I. Hence under conditions
of crystallization, hexokinase I likes to dimerize and form
extended linear chains, comprised of juxtaposed dimers.
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Table 1
Statistics of data collection and re¢nement
Resolution limit (Aî ) of data 2.8
No. of measurements 169 203
No. of unique re£ections 62 017
Completeness of data (%) overall/last shell 95/67 (2.9^2.8 Aî )
Rsyma 0.065
Resolution range for re¢nement 8^2.8 Aî
No. of re£ections in re¢nementb 49 239
Total number of atoms 14 362
Total number of solvent sites 182
R-factorc/Rfreed 0.188/0.247
Mean B-values (Aî 2)
N-terminal half (chains A/B) 35/36
C-terminal half (chains A/B) 26/33
Root-mean-squared deviations
Bond lengths (Aî ) 0.007
Bond angles (deg.) 1.2
aRsym =gjgiMIij3GIjfM/gigjIij.
bOnly re£ections with MFobsMsc(Fobs) were used in the re¢nement.
cR-factor =gMMFobsM3MFcalcMM/gMFobsM, for all re£ections MFobsMs 2c.
dR-factor based on 10% of the data excluded from re¢nement.
Fig. 3. Model for membrane associated dimers of hexokinase I. The N-terminal helices, drawn in boldlines, mark the location of structural ele-
ments necessary for membrane association. Glucose molecules (labeled Glc) mark the open active sites of C-terminal halves of hexokinase I.
Porin molecules, with a stoichiometry of two per hexokinase I dimer, could interact with N-terminal elements and C-terminal halves of adjacent
dimers.
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The crystallographic information above may be useful in
modeling porin-associated hexokinase I at the outer mem-
brane of the mitochondrion, but accurate information regard-
ing the stoichiometry of porin and hexokinase I in such mem-
brane complexes is essential, and for the most part
unavailable. One can, however, estimate a total number of
porin molecules of 42 000 in a single rat liver mitochondrion,
assuming 1.5% of the total mitochondrial protein as porin
[29], an Mr for porin of 30 000 and 7.2U109 mitochondria
per milligram of mitochondrial protein [30]. Similarly, on
the basis of the speci¢c activity of puri¢ed hexokinase (60
units/mg), the units of hexokinase I that can bind per milli-
gram of rat liver mitochondria (1.1 units/mg, [17]) and an Mr
of 100 000 for the hexokinase I monomer, approximately
15 000 monomers can bind to a single mitochondrion. The
ratio of porin monomers to hexokinase monomers is approx-
imately 3. Choosing a lower limit of 0.5% for the total mito-
chondrial protein as porin gives a ratio of 1 porin monomer
for each hexokinase I monomer.
Hexokinase I binds with cooperativity to the mitochondrial
membrane (Hill coe⁄cient of 3 [13]), and hence interactions
must occur between hexokinase I subunits. As noted above,
the most signi¢cant interactions observed in crystal structures
of hexokinase I are the subunit interface of the dimer and the
aforementioned interface a. These two types of interface lead
to the association of hexokinase I dimers as in the glucose/Pi
complex (Fig. 3). The N-terminal elements, necessary for
membrane association [31], project from the same face of
the assembly of hexokinase I dimers. Furthermore, the C-ter-
minal domains from two separate dimers are in contact and
face the membrane with open active sites. A porin dimer with
outer ori¢ces facing the C-terminal domains, could further
stabilize this pairing of hexokinase I dimers, by interacting
with N-terminal elements from adjacent hexokinase I dimers.
This basic unit, if extended as a chain, would account for the
binding cooperativity of hexokinase I to the membrane, and
be consistent with a one-to-one ratio of porin to hexokinase I
monomer. Other models are possible with di¡erent porin to
hexokinase I ratios, but they share the common attribute of
being linear chains of hexokinase I dimers, crosslinked by
porins.
The best (and perhaps only) characterized porin complex
from a eukaryotic system is from Neurospora crassa, where
porins naturally associate into two-dimensional crystals [32].
The mitochondria of N. crassa are rich in porin and tight
junctions, and perhaps extended porin arrays observed in
such membranes are good models for porin complexes at tight
junctions of other mitochondria. Hexokinase I putatively
binds preferentially to the tight junctions of mitochondria
[13]. The association of hexokinase I with tight junctions
may be simply a cooperative assembly of hexokinase I dimers
into linear chains over the surface of extended (and pre-exist-
ing) porin arrays. We caution readers, however, that the
above picture is a basis for the design of experiments, rather
than a rigorous account of porin-hexokinase I interactions.
More precise data regarding porin-hexokinase I interactions
are a prerequisite to a better model.
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